PMV Pharmaceuticals, Inc. (PMVP) Financials

PMVP Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 82.1 million 10.6 million
March 31, 2026 96.6 million 8.6 million
Dec. 31, 2025 116.6 million 11.9 million
Sept. 30, 2025 133.8 million 12.8 million

PMVP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -14.6 million 1.5 million
March 31, 2026 -19.7 million 1.4 million
Dec. 31, 2025 -17.2 million 1.4 million
Sept. 30, 2025 -19.8 million 1.4 million

PMVP Net Income

No data available :(

PMVP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 79.4 million - -
March 31, 2026 93.5 million - 293000
Dec. 31, 2025 112.9 million - 838000
Sept. 30, 2025 129.3 million - 931000

PMVP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 53.4 million
March 31, 2026 53.3 million
Dec. 31, 2025 53.3 million
Sept. 30, 2025 53.0 million

PMVP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 14.7 million 4.2 million -
March 31, 2026 - 15.3 million 3.7 million -
Dec. 31, 2025 15000 15.8 million 3.4 million -
Sept. 30, 2025 1000 18.2 million 4.3 million -

PMVP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 34000
Dec. 31, 2025 - 33000
Sept. 30, 2025 - 32000

PMVP

Price: $1.21

52 week price:
1.02
1.91

Earnings Per Share: -1.42 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 230900

Market Capitalization: 95.5 million

Links: